BioTelemetry Company Profile (NASDAQ:BEAT)

About BioTelemetry

BioTelemetry logoBioTelemetry, Inc. (BioTelemetry), formerly CardioNet, Inc., provides cardiac monitoring services, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. The Company operates in three segments: patient services, product and research services. The patient services business segment's principal focus is on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders, through its core Mobile Cardiac Outpatient Telemetry(MCOT), event and Holter services in a healthcare setting. The product business segment focuses on the development, manufacturing, testing and marketing of medical devices to medical companies, clinics and hospitals. The Company's research services focuses on providing cardiac safety monitoring services for drug and medical treatment trials in a research environment. In August 2012, the Company completed the acquisition of Cardiocore Lab, Inc. (Cardiocore).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: BEAT
  • CUSIP:
Key Metrics:
  • Previous Close: $24.95
  • 50 Day Moving Average: $23.15
  • 200 Day Moving Average: $20.40
  • 52-Week Range: $10.96 - $25.94
  • Trailing P/E Ratio: 47.98
  • Foreward P/E Ratio: 28.35
  • P/E Growth: 1.42
  • Market Cap: $704.36M
  • Outstanding Shares: 28,231,000
  • Beta: 0.9
  • Net Margins: 7.58%
  • Return on Equity: 26.70%
  • Return on Assets: 15.81%
  • Debt-to-Equity Ratio: 0.26%
  • Current Ratio: 1.60%
  • Quick Ratio: 1.51%
Additional Links:
Companies Related to BioTelemetry:

Analyst Ratings

Consensus Ratings for BioTelemetry (NASDAQ:BEAT) (?)
Ratings Breakdown: 5 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $25.50 (2.20% upside)

Analysts' Ratings History for BioTelemetry (NASDAQ:BEAT)
DateFirmActionRatingPrice TargetDetails
12/13/2016GabelliReiterated RatingBuyView Rating Details
12/2/2016Dougherty & CoInitiated CoverageBuy$26.00View Rating Details
10/5/2016Lake Street CapitalReiterated RatingBuy$24.00View Rating Details
9/13/2016SidotiInitiated CoverageBuy$27.00View Rating Details
8/3/2016Benchmark Co.Boost Price TargetBuy$20.00 -> $25.00View Rating Details
(Data available from 2/22/2015 forward)


Earnings History for BioTelemetry (NASDAQ:BEAT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/22/2017Q4 2016$0.18$0.23$53.75 million$53.96 millionViewListenView Earnings Details
11/2/2016Q316$0.18$0.21$52.92 million$53.10 millionViewN/AView Earnings Details
8/2/2016Q2$0.17$0.20$50.27 million$52.68 millionViewListenView Earnings Details
4/26/2016Q1$0.10$0.20$46.54 million$48.60 millionViewListenView Earnings Details
2/17/2016Q415$0.11$0.15$45.89 million$46.70 millionViewListenView Earnings Details
11/9/2015Q3$0.11$0.13$46.05 million$43.49 millionViewN/AView Earnings Details
8/6/2015Q2$0.09$0.12$45.75 million$44.81 millionViewListenView Earnings Details
5/6/2015Q115$0.02$0.06$43.80 million$43.40 millionViewListenView Earnings Details
2/19/2015Q414$0.06$0.05$43.40 million$43.70 millionViewListenView Earnings Details
10/30/2014Q214$0.02$0.06$42.00 million$43.00 millionViewListenView Earnings Details
7/31/2014Q114$0.01$0.02$40.95 million$42.70 millionViewListenView Earnings Details
5/6/2014Q413($0.02)($0.04)$38.40 million$37.16 millionViewListenView Earnings Details
2/26/2014Q313($0.04)$0.05$32.26 million$33.10 millionViewListenView Earnings Details
11/5/2013($0.05)($0.12)$32.79 million$31.90 millionViewListenView Earnings Details
7/30/2013Q2 2013$0.02$27.50 million$32.10 millionViewListenView Earnings Details
2/13/2013Q4 2012($0.09)$26.80 million$30.00 millionViewListenView Earnings Details
11/5/2012Q312($0.09)($0.08)$26.49 million$27.00 millionViewN/AView Earnings Details
8/8/2012($0.04)($0.01)ViewN/AView Earnings Details
5/8/2012($0.12)($0.10)ViewN/AView Earnings Details
2/22/2012($0.13)($0.04)ViewN/AView Earnings Details
11/8/2011($0.09)($0.21)ViewN/AView Earnings Details
8/8/2011($0.06)($0.05)ViewN/AView Earnings Details
5/3/2011($0.15)($0.02)ViewN/AView Earnings Details
2/17/2011($0.16)($0.13)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for BioTelemetry (NASDAQ:BEAT)
Current Year EPS Consensus Estimate: $0.80 EPS
Next Year EPS Consensus Estimate: $0.88 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.08$0.09$0.09
Q2 20161$0.16$0.16$0.16
Q3 20161$0.16$0.16$0.16
Q4 20161$0.18$0.18$0.18
Q1 20171$0.20$0.20$0.20
Q2 20171$0.20$0.20$0.20
Q3 20171$0.19$0.19$0.19
Q4 20171$0.22$0.22$0.22
(Data provided by Zacks Investment Research)


Dividend History for BioTelemetry (NASDAQ:BEAT)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for BioTelemetry (NASDAQ:BEAT)
Insider Ownership Percentage: 11.00%
Institutional Ownership Percentage: 84.23%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/21/2017Fred BroadwaySVPSell8,070$24.81$200,216.70View SEC Filing  
9/19/2016George HrenkoSVPSell1,061$18.50$19,628.50View SEC Filing  
9/13/2016Heather C GetzCFOSell5,866$18.23$106,937.18View SEC Filing  
9/13/2016Joseph H CapperInsiderSell26,847$18.23$489,420.81View SEC Filing  
9/13/2016Peter FerolaGeneral CounselSell4,352$18.23$79,336.96View SEC Filing  
9/9/2016Fred BroadwaySVPSell3,146$17.84$56,124.64View SEC Filing  
9/8/2016George HrenkoSVPSell3,491$18.06$63,047.46View SEC Filing  
9/8/2016Heather C GetzCFOSell2,979$18.10$53,919.90View SEC Filing  
9/8/2016Joseph H CapperInsiderSell13,632$18.10$246,739.20View SEC Filing  
9/8/2016Peter FerolaGeneral CounselSell2,210$18.10$40,001.00View SEC Filing  
9/7/2016Daniel WisniewskiSVPSell9,225$18.51$170,754.75View SEC Filing  
9/7/2016Heather C GetzCFOSell18,945$18.52$350,861.40View SEC Filing  
9/7/2016Joseph H CapperInsiderSell86,681$18.52$1,605,332.12View SEC Filing  
9/7/2016Peter FerolaGeneral CounselSell14,053$18.52$260,261.56View SEC Filing  
9/6/2016Fred BroadwaySVPSell4,662$18.28$85,221.36View SEC Filing  
9/6/2016Heather C GetzCFOSell6,686$18.29$122,286.94View SEC Filing  
9/6/2016Joseph H CapperCEOSell30,595$18.29$559,582.55View SEC Filing  
9/6/2016Peter FerolaGeneral CounselSell4,960$18.29$90,718.40View SEC Filing  
9/2/2016Fred BroadwaySVPSell4,466$18.75$83,737.50View SEC Filing  
9/2/2016Heather C GetzCFOSell6,547$18.75$122,756.25View SEC Filing  
9/2/2016Joseph H CapperCEOSell29,953$18.75$561,618.75View SEC Filing  
9/2/2016Peter FerolaGeneral CounselSell4,856$18.75$91,050.00View SEC Filing  
9/1/2016Fred BroadwaySVPSell7,525$19.25$144,856.25View SEC Filing  
9/1/2016Heather C GetzCFOSell10,408$18.59$193,484.72View SEC Filing  
9/1/2016Joseph H CapperInsiderSell47,622$18.59$885,292.98View SEC Filing  
9/1/2016Peter FerolaGeneral CounselSell7,722$18.59$143,551.98View SEC Filing  
8/30/2016Fred BroadwaySVPSell12,121$19.07$231,147.47View SEC Filing  
8/30/2016Heather C GetzCFOSell17,482$19.07$333,381.74View SEC Filing  
8/30/2016Joseph H CapperInsiderSell79,986$19.07$1,525,333.02View SEC Filing  
8/30/2016Peter FerolaGeneral CounselSell12,970$19.07$247,337.90View SEC Filing  
8/25/2016Fred BroadwaySVPSell5,877$19.16$112,603.32View SEC Filing  
8/25/2016Heather C GetzCFOSell8,477$19.16$162,419.32View SEC Filing  
8/25/2016Joseph H CapperInsiderSell38,785$19.16$743,120.60View SEC Filing  
8/25/2016Peter FerolaGeneral CounselSell6,289$19.16$120,497.24View SEC Filing  
8/24/2016George HrenkoSVPSell7,473$20.11$150,282.03View SEC Filing  
8/24/2016Heather C GetzCFOSell8,778$20.11$176,525.58View SEC Filing  
8/24/2016Joseph H CapperCEOSell40,160$20.11$807,617.60View SEC Filing  
8/24/2016Peter FerolaGeneral CounselSell6,512$20.11$130,956.32View SEC Filing  
8/23/2016George HrenkoSVPSell3,165$20.67$65,420.55View SEC Filing  
8/23/2016Heather C GetzCFOSell3,717$20.67$76,830.39View SEC Filing  
8/23/2016Joseph H CapperCEOSell17,008$20.67$351,555.36View SEC Filing  
8/23/2016Peter FerolaGeneral CounselSell2,758$20.67$57,007.86View SEC Filing  
8/22/2016George HrenkoSVPSell4,149$20.85$86,506.65View SEC Filing  
8/22/2016Heather C GetzCFOSell4,874$20.85$101,622.90View SEC Filing  
8/22/2016Joseph H CapperCEOSell22,298$20.85$464,913.30View SEC Filing  
8/22/2016Peter FerolaGeneral CounselSell3,616$20.85$75,393.60View SEC Filing  
8/19/2016Daniel WisniewskiSVPSell9,025$20.96$189,164.00View SEC Filing  
8/19/2016Heather C GetzCFOSell9,026$20.96$189,184.96View SEC Filing  
8/19/2016Joseph H CapperInsiderSell9,049$20.96$189,667.04View SEC Filing  
8/19/2016Peter FerolaGeneral CounselSell9,035$20.96$189,373.60View SEC Filing  
5/9/2014Ronald AhrensDirectorBuy6,000$7.37$44,220.00View SEC Filing  
11/12/2013Ronald AhrensDirectorBuy5,000$11.73$58,650.00View SEC Filing  
11/12/2012Ronald A AhrensDirectorBuy15,000$2.22$33,300.00View SEC Filing  
9/5/2012Joseph H CapperCEOBuy23,540$2.25$52,965.00View SEC Filing  
8/31/2012Joseph H CapperCEOBuy2,600$2.28$5,928.00View SEC Filing  
8/29/2012Joseph H CapperCEOBuy10,800$2.30$24,840.00View SEC Filing  
8/28/2012Joseph H CapperCEOBuy1,300$2.19$2,847.00View SEC Filing  
8/27/2012Joseph H CapperCEOBuy1,600$2.12$3,392.00View SEC Filing  
8/23/2012Joseph H CapperCEOBuy9,600$2.08$19,968.00View SEC Filing  
8/20/2012Joseph H CapperCEOBuy14,160$1.97$27,895.20View SEC Filing  
8/17/2012Joseph H CapperCEOBuy9,800$2.10$20,580.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for BioTelemetry (NASDAQ:BEAT)
DateHeadline logoInsider Trading Activity BioTelemetry, Inc. (NASDAQ:BEAT) – SVP Sold 8,070 shares of Stock (NASDAQ:BEAT) - February 22 at 8:56 PM logoBioTelemetry, Inc. Reports Fourth Quarter and Full Year 2016 Financial Results (NASDAQ:BEAT) - February 22 at 8:56 PM logo4:10 pm BioTelemetry beats by $0.05, reports revs in-line (NASDAQ:BEAT) - February 22 at 8:56 PM logoBIOTELEMETRY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi (NASDAQ:BEAT) - February 22 at 8:56 PM logoBioTelemetry posts 4Q profit (NASDAQ:BEAT) - February 22 at 8:56 PM
News IconBioTelemetry, Inc. (BEAT) expected to see a positive post earnings price reaction - Post Analyst (NASDAQ:BEAT) - February 22 at 3:55 PM logoNoteworthy Wednesday Option Activity: HLF, FIVN, BEAT (NASDAQ:BEAT) - February 16 at 8:48 AM logoTechnology and Telemedicine Advancements in Healthcare Boosting Improved Patient Care (NASDAQ:BEAT) - February 16 at 8:48 AM logo4 Stocks To Watch: BEAT, EXAS, SHOP, ZYNE (NASDAQ:BEAT) - February 16 at 8:48 AM
News IconTurbulence Hits These Shares as Volume Spikes: BioTelemetry, Inc. (NASDAQ:BEAT) - Aiken Advocate (NASDAQ:BEAT) - February 14 at 3:30 PM logoBreakout Watch: Why Are Top Funds Buying This Healthy Tech IPO? (NASDAQ:BEAT) - February 14 at 3:30 PM
News IconMarket Focus- Increased Volatility Recorded on Shares of BioTelemetry, Inc. (NASDAQ:BEAT) - Aiken Advocate (NASDAQ:BEAT) - February 13 at 9:23 PM logoBIOTELEMETRY, INC. Files SEC form 8-K/A, Financial Statements and Exhibits (NASDAQ:BEAT) - February 13 at 9:23 PM logoBioTelemetry, Inc. to Release Fourth Quarter 2016 Earnings Results on February 22, 2017 (NASDAQ:BEAT) - February 13 at 10:22 AM
News IconSprint & BioTelemetry, Inc. Receive a 2017 IoT Evolution Business ... - IoT Evolution World (blog) (NASDAQ:BEAT) - February 2 at 4:01 PM
News IconCannell Capital LLC Has Trimmed Stake in Biotelemetry INC (BEAT) by $7.55 Million as Valuation Rose (NASDAQ:BEAT) - January 25 at 4:06 PM
News IconForget BioTelemetry (BEAT) and AngioDynamics (ANGO) - CardioComm Solutions (EKGGF, CVE:EKG) is the Heart ... - SmallCap Network (NASDAQ:BEAT) - January 20 at 10:01 PM
News IconShedding Positions Or Stocking Up? What Are Insiders Doing With BioTelemetry, Inc. (NASDAQ:BEAT) - Aiken Advocate (NASDAQ:BEAT) - January 20 at 3:03 AM
News IconImportant Short Interest Filing: Biotelemetry Incorporated (NASDAQ:BEAT) Reports Increase in Sellers; Strong ... - Baxley Report (NASDAQ:BEAT) - January 18 at 2:38 AM logoSentiments And Ratings Alert: BioTelemetry, Inc. (NASDAQ:BEAT) - Investor Newswire (NASDAQ:BEAT) - January 11 at 4:14 PM
News IconMarket Scope: Taking a Look at BioTelemetry, Inc. (NASDAQ:BEAT) - Wall Street Beacon (NASDAQ:BEAT) - January 9 at 8:08 AM logoCan Shares Of BioTelemetry, Inc. (NASDAQ:BEAT) Hit $26? - Investor Newswire (NASDAQ:BEAT) - January 7 at 4:25 PM
News IconBioTelemetry, Inc. (NASDAQ:BEAT) Valuation According To Analysts - UK Market News (NASDAQ:BEAT) - January 5 at 4:15 PM logoEPS Projection BioTelemetry, Inc. (NASDAQ:BEAT) At $0.21 - Investor Newswire (NASDAQ:BEAT) - January 1 at 8:53 PM logoBioTelemetry, Inc. (NASDAQ:BEAT) Strong Buy Recommendations At 4 - Investor Newswire (NASDAQ:BEAT) - December 31 at 3:50 PM logoETFs with exposure to BioTelemetry, Inc. : December 30, 2016 (NASDAQ:BEAT) - December 30 at 4:10 PM
News IconHome Business BioTelemetry Inc (BEAT) Gets FDA Approval, Shares Move Up With Trading Volume - BNB Daily (blog) (NASDAQ:BEAT) - December 28 at 9:04 PM
News IconInvestor Update: Looking at Shares of BioTelemetry, Inc. (NASDAQ:BEAT) - Wall Street Beacon (NASDAQ:BEAT) - December 26 at 9:56 AM
News IconValue Score Review for BioTelemetry, Inc. (NASDAQ:BEAT) - Wall Street Beacon (NASDAQ:BEAT) - December 23 at 3:58 PM
News IconInvestor Corner: Checking the Numbers for BioTelemetry, Inc. (NASDAQ:BEAT) - Business Daily Leader (NASDAQ:BEAT) - December 21 at 2:17 AM logoBioTelemetry Inc. (BEAT) Has Broken Out To A New High For The Year (NASDAQ:BEAT) - December 20 at 4:10 PM
News IconStock Spotlight: Checking on Shares of BioTelemetry, Inc. (NASDAQ ... - OIB News (NASDAQ:BEAT) - December 19 at 5:39 PM
News IconUpdate on Valuation Formula's For BioTelemetry, Inc. (NASDAQ:BEAT) - Marion Business Daily (NASDAQ:BEAT) - December 19 at 5:39 PM logoStocks Higher As 3 Medicals Hit Buy Points; No 'Star Wars' Hasbro Bump (NASDAQ:BEAT) - December 19 at 5:39 PM
News IconInvestor Chatter: Looking at Shares of BioTelemetry, Inc. (NASDAQ:BEAT) - Liberty News (NASDAQ:BEAT) - December 18 at 8:52 PM
News IconEquity Review: Looking Closer at Shares of BioTelemetry, Inc. (NASDAQ:BEAT) - Business Daily Leader (NASDAQ:BEAT) - December 17 at 8:57 PM
News IconVC Score In Focus for BioTelemetry, Inc. (NASDAQ:BEAT) - The Business Journal (NASDAQ:BEAT) - December 17 at 3:56 PM logoETFs with exposure to BioTelemetry, Inc. : December 16, 2016 (NASDAQ:BEAT) - December 16 at 4:07 PM logoAre You Monitoring This Potential Medical-Stock Breakout? (NASDAQ:BEAT) - December 16 at 4:07 PM
News IconBioTelemetry, Inc. (NASDAQ:BEAT) Under Analyst Spotlight - UK Market News (NASDAQ:BEAT) - December 15 at 3:45 PM
News IconEquity in Focus: BioTelemetry, Inc. (NASDAQ:BEAT) - OIB News (NASDAQ:BEAT) - December 15 at 3:45 PM logoAre You Monitoring This Potential Medical Stock Breakout? (NASDAQ:BEAT) - December 15 at 3:45 PM logoGoBio Or Go Home: Top Medical Stock BioTelemetry Tests Buy Point (NASDAQ:BEAT) - December 15 at 3:45 PM
News IconMF Rank Review for BioTelemetry, Inc. (NASDAQ:BEAT) - Liberty News (NASDAQ:BEAT) - December 15 at 2:44 AM
News IconTrading Watch: Checking in on Shares of BioTelemetry, Inc. (NASDAQ:BEAT) - The Business Journal (NASDAQ:BEAT) - December 13 at 3:56 PM
News IconInvestor Hub: Looking at Shares of BioTelemetry, Inc. (NASDAQ:BEAT) - OIB News (NASDAQ:BEAT) - December 13 at 3:56 PM
News IconInvestor Wire: Keeping an Eye on BioTelemetry, Inc. (NASDAQ:BEAT) - Liberty News (NASDAQ:BEAT) - December 13 at 2:06 AM
News IconEquity in Focus: BioTelemetry, Inc. (NASDAQ:BEAT) - Liberty News (NASDAQ:BEAT) - December 10 at 10:50 AM
News IconMarket Survey: Checking on Shares of BioTelemetry, Inc. (NASDAQ:BEAT) - OIB News (NASDAQ:BEAT) - December 8 at 9:56 PM logoHedge Funds Are Crazy About BioTelemetry, Inc. (BEAT) (NASDAQ:BEAT) - December 8 at 4:50 PM


What is BioTelemetry's stock symbol?

BioTelemetry trades on the NASDAQ under the ticker symbol "BEAT."

Where is BioTelemetry's stock going? Where will BioTelemetry's stock price be in 2017?

5 analysts have issued twelve-month price targets for BioTelemetry's shares. Their predictions range from $24.00 to $27.00. On average, they anticipate BioTelemetry's stock price to reach $25.50 in the next twelve months.

When will BioTelemetry announce their earnings?

BioTelemetry is scheduled to release their next quarterly earnings announcement on Wednesday, February, 22nd 2017.

Who owns BioTelemetry stock?

BioTelemetry's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Dimensional Fund Advisors LP (5.11%), Renaissance Technologies LLC (3.89%), State Street Corp (2.50%), Thompson Siegel & Walmsley LLC (2.34%), Cortina Asset Management LLC (2.01%) and Allianz Asset Management AG (1.38%). Company insiders that own BioTelemetry stock include Daniel Wisniewski, Fred Broadway, George Hrenko, Heather C Getz, Joseph H Capper and Peter Ferola.

Who sold BioTelemetry stock? Who is selling BioTelemetry stock?

BioTelemetry's stock was sold by a variety of institutional investors in the last quarter, including Thompson Siegel & Walmsley LLC, Royce & Associates LP, Allianz Asset Management AG, Two Sigma Investments LP, Bogle Investment Management L P DE, Oxford Asset Management, AQR Capital Management LLC and GSA Capital Partners LLP. Company insiders that have sold BioTelemetry stock in the last year include Daniel Wisniewski, Fred Broadway, George Hrenko, Heather C Getz, Joseph H Capper and Peter Ferola.

Who bought BioTelemetry stock? Who is buying BioTelemetry stock?

BioTelemetry's stock was bought by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Nicholas Investment Partners LP, Ancora Advisors LLC, Renaissance Technologies LLC, Systematic Financial Management LP, Guggenheim Capital LLC, Dimensional Fund Advisors LP and A.R.T. Advisors LLC.

How do I buy BioTelemetry stock?

Shares of BioTelemetry can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of BioTelemetry stock cost?

One share of BioTelemetry stock can currently be purchased for approximately $24.95.

BioTelemetry (NASDAQ:BEAT) Chart for Wednesday, February, 22, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for BioTelemetry (NASDAQ:BEAT)

Earnings History Chart

Earnings by Quarter for BioTelemetry (NASDAQ:BEAT)

Dividend History Chart

Dividend Payments by Quarter for BioTelemetry (NASDAQ:BEAT)

Last Updated on 2/22/2017 by Staff